Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Stages II-III Breast Cancer × Taxes × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 12 Pancreatic Neoplasms 5 Triple Negative Breast Neoplasms 4 Fallopian Tube Neoplasms 4 Ovarian Neoplasms 3 Lung Neoplasms 3 Adenocarcinoma of Lung 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Inflammatory Breast Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms, Male 2 Adenocarcinoma, Bronchiolo-Alveolar 2 Adenocarcinoma Of Esophagus 2 Turcot syndrome 1 Thrombocytosis 1 Stages II-III Breast Cancer 1 Stage IIIA Lung Non-Small Cell Cancer AJCC v7 1 Stage IA Uterine Sarcoma 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 NSCLC 1 Myeloproliferative Disorders 1

Interventions

Taxes 1 Doxorubicin 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01090128 2017-03-31

NAC

University of Utah

Phase 1 Terminated

Stages II-III Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡